BioSpace News Archive

Ascendis Pharma A/S to Present New Endocrinology Results at Four Medical Meetings in May 2022

Ascendis Pharma A/S announced that the company will present clinical and research outcomes and host informational booths and events at four medical meetings during May.

May 1, 2022
·
6 min read
Biotech Beach

Exagen Announces Five-Week Campaign for Lupus Awareness Month

Exagen Inc., a leading provider of autoimmune testing solutions, announced, in recognition of Lupus Awareness Month, the launch of a five-week awareness campaign to highlight important and impactful work being done to help those suffering from Systemic Lupus Erythematosus.

May 1, 2022
·
2 min read
Drug Development

Rezolute Announces Positive Data from its Phase 2b (RIZE) Study of RZ358 in Patients with Congenital Hyperinsulinism

Rezolute, Inc. announced positive results from its Phase 2b RIZE study of RZ358 in patients with congenital hyperinsulinism, which were unveiled today in a late-breaking oral presentation at the Pediatric Endocrine Society 2022 Annual Meeting.

May 1, 2022
·
12 min read
BioCapital

Kala Pharmaceuticals to Present Clinical Data for KPI-012, its Mesenchymal Stem Cell Secretome Product, for the Treatment of PCED at the 2022 ARVO Annual Meeting

Kala Pharmaceuticals, Inc. reported clinical data from a Phase 1b trial of KPI-012, its novel, cell-free secretome therapy for the treatment of severe ocular diseases driven by impaired healing.

May 1, 2022
·
7 min read
Biotech Bay

Adverum Biotechnologies Presents Additional Efficacy and Safety Data from the OPTIC Trial of ADVM-022 in Wet AMD at the ARVO 2022 Annual Meeting

Adverum Biotechnologies, Inc. announced the presentation of new post-hoc analysis from the OPTIC study of ADVM-022 in wet age-related macular degeneration during The Association for Research in Vision and Ophthalmology 2022 Annual Meeting in Denver, Colorado and virtually.

May 1, 2022
·
7 min read